542 related items for PubMed ID: 27749951
1. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.
Chen S, Dong Y, Kiuchi MG, Wang J, Li R, Ling Z, Zhou T, Wang Z, Martinek M, Pürerfellner H, Liu S, Krucoff MW.
JAMA Pediatr; 2016 Dec 01; 170(12):1156-1163. PubMed ID: 27749951
[Abstract] [Full Text] [Related]
2. Corticosteroids for the treatment of Kawasaki disease in children.
Wardle AJ, Connolly GM, Seager MJ, Tulloh RM.
Cochrane Database Syst Rev; 2017 Jan 27; 1(1):CD011188. PubMed ID: 28129459
[Abstract] [Full Text] [Related]
3. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis.
Chen S, Dong Y, Yin Y, Krucoff MW.
Heart; 2013 Jan 27; 99(2):76-82. PubMed ID: 22869678
[Abstract] [Full Text] [Related]
4. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Wooditch AC, Aronoff SC.
Pediatrics; 2005 Oct 27; 116(4):989-95. PubMed ID: 16199713
[Abstract] [Full Text] [Related]
5. Corticosteroids for the treatment of Kawasaki disease in children.
Green J, Wardle AJ, Tulloh RM.
Cochrane Database Syst Rev; 2022 May 27; 5(5):CD011188. PubMed ID: 35622534
[Abstract] [Full Text] [Related]
6. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
Friedman KG, Gauvreau K, Baker A, Son MB, Sundel R, Dionne A, Giorgio T, De Ferranti S, Newburger JW.
Arch Dis Child; 2021 Mar 27; 106(3):247-252. PubMed ID: 32943389
[Abstract] [Full Text] [Related]
7. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM, Kahn R, Mossberg M, Kucera F, Tulloh R, Standing JF, Swallow V, McCormack R, Herberg J, Levin M, Wan M, Klein N, Connon R, Walker AS, Brogan P.
Trials; 2023 Jan 26; 24(1):60. PubMed ID: 36703139
[Abstract] [Full Text] [Related]
8. The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness.
Yang TJ, Lin MT, Lu CY, Chen JM, Lee PI, Huang LM, Wu MH, Chang LY.
J Microbiol Immunol Infect; 2018 Jun 26; 51(3):321-331. PubMed ID: 28927685
[Abstract] [Full Text] [Related]
9. A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease.
Zhu BH, Lv HT, Sun L, Zhang JM, Cao L, Jia HL, Yan WH, Shen YP.
Eur J Pediatr; 2012 Mar 26; 171(3):571-8. PubMed ID: 22057683
[Abstract] [Full Text] [Related]
10. Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High-Risk Patients With Kawasaki Disease.
Ae R, Abrams JY, Maddox RA, Schonberger LB, Nakamura Y, Kuwabara M, Makino N, Matsubara Y, Kosami K, Sasahara T, Belay ED.
J Am Heart Assoc; 2020 Sep 26; 9(17):e015308. PubMed ID: 32811256
[Abstract] [Full Text] [Related]
11. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
Lancet Child Adolesc Health; 2018 Dec 26; 2(12):855-862. PubMed ID: 30337183
[Abstract] [Full Text] [Related]
12. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
Platt B, Belarski E, Manaloor J, Ofner S, Carroll AE, John CC, Wood JB.
JAMA Netw Open; 2020 Jan 03; 3(1):e1918565. PubMed ID: 31899532
[Abstract] [Full Text] [Related]
13. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome.
Inoue Y, Okada Y, Shinohara M, Kobayashi T, Kobayashi T, Tomomasa T, Takeuchi K, Morikawa A.
J Pediatr; 2006 Sep 03; 149(3):336-341. PubMed ID: 16939743
[Abstract] [Full Text] [Related]
14. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM, Silverman ED, McCrindle BW, Yeung RS.
J Pediatr; 2002 Apr 03; 140(4):450-5. PubMed ID: 12006960
[Abstract] [Full Text] [Related]
15. Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease.
Zhao CN, Du ZD, Gao LL.
Chin Med J (Engl); 2016 Apr 20; 129(8):922-8. PubMed ID: 27064036
[Abstract] [Full Text] [Related]
16. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May 20; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
17. Kawasaki disease: a comprehensive review of treatment options.
Patel RM, Shulman ST.
J Clin Pharm Ther; 2015 Dec 20; 40(6):620-5. PubMed ID: 26547265
[Abstract] [Full Text] [Related]
18. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct 20; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
19. Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease: An Analysis of Post RAISE.
Miyata K, Miura M, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H.
Circ Cardiovasc Qual Outcomes; 2021 Feb 20; 14(2):e007191. PubMed ID: 33541111
[Abstract] [Full Text] [Related]
20. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
Kibata T, Suzuki Y, Hasegawa S, Matsushige T, Kusuda T, Hoshide M, Takahashi K, Okada S, Wakiguchi H, Moriwake T, Uchida M, Ohbuchi N, Iwai T, Hasegawa M, Ichihara K, Yashiro M, Makino N, Nakamura Y, Ohga S.
Int J Cardiol; 2016 Jul 01; 214():209-15. PubMed ID: 27070994
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
